Upstream Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

WALTHAM, Mass., June 04, 2025 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, today announced that Rand Sutherland, MD, Chief Executive Officer of Upstream Bio, will participate in a fireside chat at the Goldman Sachs 46^th Annual Global Healthcare Conference on Wednesday, June 11, 2025, at 9:20 a.m. ET.

Read more at globenewswire.com